Group 3A: Lee/Oesterreich Lab

Poster #1: Transcriptomic Analysis Identifies Enrichment of cAMP/PKA/CREB Signaling in Invasive Lobular Breast Cancer

Poster #2: Predicting Response to HER2 Tyrosine Kinase Inhibitors & Antibody Drug Conjugates in ERBB2 Mutant ILC Using CRISPR/Cas9 Knock-In Cell Lines & Patient-Derived Organoids